You just read:

RXi Pharmaceuticals Fortifies its Novel RNAi Patent Portfolio with Notice of Allowance for Lead Clinical Candidate RXI-109

News provided by

RXi Pharmaceuticals Corporation

Apr 19, 2016, 07:02 ET